Effect of Benson's relaxation technique via virtual reality on Iraqi cancer patients

Effect of Benson Relaxation via Virtual Reality on Sleep Disturbance in Patients with Cancer: A Randomized Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230310057672N5

Enrollment

Registered

2024-11-21

Start date

2024-12-12

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disturbance for patients with cancer. Sleep disorder, unspecified

Interventions

Intervention 1: Intervention group: After the initial assessment using The Jenkins sleep scale(JSS ), participants in the intervention group receive the Benson's Relaxation Technique (BRT) via VR(vide

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Hospitalized cancer patients agreed to participate in the study. All participants were educated, fully conscious, and over 18 years of age.

Exclusion criteria

Exclusion criteria: Participants in other studies, those diagnosed with a brain tumor, those with learning difficulties, and those with a physical disability were excluded, The study excluded participants who had emotional distress in the previous month

Design outcomes

Primary

Measure	Time frame
The primary outcome to assessment sleep of patients with cancer. Timepoint: After implementing the clinical trial intervention ( Benson relaxation technique via VR to cancer patients), the results of assess for sleep in cancer patients (sleep quality) for both groups appear. Sleep quality will be evaluated after past four week. Method of measurement: Measurement method before clinical intervention using " Jenkins sleep scale(JSS )" is a self-report survey to evaluate the quality of sleep and disruptions experienced within a period of past four week. and takes 5–10 minutes to complete.	—

Measure

Time frame

The primary outcome to assessment sleep of patients with cancer. Timepoint: After implementing the clinical trial intervention ( Benson relaxation technique via VR to cancer patients), the results of assess for sleep in cancer patients (sleep quality) for both groups appear. Sleep quality will be evaluated after past four week. Method of measurement: Measurement method before clinical intervention using " Jenkins sleep scale(JSS )" is a self-report survey to evaluate the quality of sleep and disruptions experienced within a period of past four week. and takes 5–10 minutes to complete.

—

Secondary

Measure	Time frame
The primary outcome to improvement and promoting sleep of patients with cancer. Timepoint: After implementing the clinical trial intervention for approximately 7 days of applying the Benson relaxation technique via VR to cancer patients, the results of the intervention for sleep in cancer patients (sleep quality) for both groups appear. Sleep quality will be evaluated after four week. Method of measurement: Measurement method after clinical intervention using " Jenkins sleep scale(JSS )" is a self-report survey to evaluate the quality of sleep and disruptions experienced within a period of four week. and takes 5–10 minutes to complete.	—

Measure

Time frame

The primary outcome to improvement and promoting sleep of patients with cancer. Timepoint: After implementing the clinical trial intervention for approximately 7 days of applying the Benson relaxation technique via VR to cancer patients, the results of the intervention for sleep in cancer patients (sleep quality) for both groups appear. Sleep quality will be evaluated after four week. Method of measurement: Measurement method after clinical intervention using " Jenkins sleep scale(JSS )" is a self-report survey to evaluate the quality of sleep and disruptions experienced within a period of four week. and takes 5–10 minutes to complete.

—

Countries

Iraq

Contacts

Public ContactAlaa Jawad Kadhim

University of Baghdad/college of Nursing

alaaj@conursing.uobaghdad.edu.iq+964 770 352 0314

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026